Insider · CIK 0001685994
Alexander Cumbo
Files at STOK (Stoke Therapeutics, Inc.), SLDB (Solid Biosciences Inc.), CLYM (Climb Bio, Inc.), VOR (Vor Biopharma Inc.), VERV (Verve Therapeutics, Inc.). First filing Dec 4, 2024, latest Feb 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SLDB: Solid Biosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | Solid Biosciences Inc. | $45k 11,365 shares | -16% | - | |
| 37Weak | Solid Biosciences Inc. | $62k 11,114 shares | -22% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | STOK Stoke Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +39,674 | $0.00 | $0 | 39,674 | 17 d ago |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +337,500 | $0.00 | $0 | 337,500 | Aug 18, 2025 |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Restricted Stock Unitsderivative | +168,750 | $0.00 | $0 | 168,750 | Aug 18, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -136,139 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jul 16, 2025 | VOR Vor Biopharma Inc. | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jul 18, 2025 |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 5, 2025 |
| Mar 28, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 1, 2025 |
| Feb 13, 2025 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock10b5-1 | +30,031 | - | - | 72,082 | Feb 18, 2025 |
| Feb 14, 2025 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock10b5-1 | -11,365 | $3.96 | $45k | 60,717 | Feb 18, 2025 |
| Feb 13, 2025 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -30,031 | $0.00 | $0 | 90,094 | Feb 18, 2025 |
| Jan 31, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Restricted Stock Unitsderivative | +401,600 | $0.00 | $0 | 401,600 | Feb 11, 2025 |
| Dec 2, 2024 | SLDB Solid Biosciences Inc. | MOption exercise Common Stock | +28,612 | - | - | 49,598 | Dec 4, 2024 |
| Dec 3, 2024 | SLDB Solid Biosciences Inc. | SOpen-market sale Common Stock | -11,114 | $5.60 | $62k | 38,484 | Dec 4, 2024 |
| Dec 2, 2024 | SLDB Solid Biosciences Inc. | MOption exercise Restricted Stock Unitsderivative | -28,612 | $0.00 | $0 | 57,225 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.